PROGNOSTIC VALUE OF MICROVASCULAR DENSITY IN NON-SMALL CELL LUNG CARCINOMA
DOI:
https://doi.org/10.5457/ams.v43i1%20-%202.383Keywords:
non-small cell lung carcinoma, microvascular density, prognostic factor.Abstract
Background: Lung carcinoma is the most common carcinoma worldwide today, and is still a huge therapeutic and a prognostic problem. Recently, new therapeutic options, like targeted medicaments emerged, and among those are anti-angiogenic drugs. Microvascular density (MVD), as a measure of tumor angiogenesis, is a potential prognostic and predictive factor for lung carcinoma patients, and its assessment as a part of diagnostic procedure is still an open topic.
Aim: The aim of the study was to analyze MVD in lung carcinoma specimens and its connection with the histological type of tumor, tumor grade, and lymph node metastasis.
Patients and methods: Tissue samples included in this study originated from the archive of the Department of Pathology of University Clinical Center Tuzla and were obtained by surgical pulmectomy or lobectomy for NSCLC. The study included 73 patients, 40 with a diagnosis of squamocellular carcinoma (SCC), and 33 with adenocarcinoma (AC). To evaluate MVD, selected tissue samples were immunohistochemicaly stained with CD34 antibody, and analyzed using the AnalySis software.
Results: Significantly higher MVD values were found in adenocarcinoma specimens, compared to squamocellular carcinoma (p=0,002). No statistically significant correlation were found between MVD and tumor grade, or lymph node status, regardless of histological type.
Conclusion: Lung adenocarcinomas have significantly higher MVD compared to squamocellular carcinoma. The absence of significant correlation of tumor MVD with the clinical-pathological variables, knowing the results of the other similar studies, speaks for necessity of additional investigations of the subject.
Keywords: non-small cell lung carcinoma, microvascular density, prognostic factor.
Published
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
